Medical School: The Chicago Medical School, 1999
Internal Medicine Residency: Columbia-Presbyterian Medical Center, 2002
Infectious Disease Fellowship: Massachusetts General Hospital and Brigham and Women's Hospital, 2004
Infectious Disease Faculty: University of Alabama at Birmingham, 2004-2008
* Univeristy of Maryland School of Medicine, Institute of Human Virology, 2008-present
* Lived and worked overseas for five years, engaged in HIV care and treatment, teaching and mentoring, and clinical reasearch; 2005-2009
Research InterestsClinical research of therapies and therapeutic strategies of HIV and its co-infections
Clinical SpecialityInfectious Disease
Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, and Saag MS. Can Routine Clinical Markers be Used Longitudinally to Monitor Antiretroviral Therapy Success in Resource Limited Settings? Clin Infect Dis January 2007;44:135-138.
Nyirenda C, Zulu I, Kabagambe E, Bagchi S, Potter D, Bosire C, Krishnasami Z, Hemburger D. Acute hypophosphataemia in a patient starting antiretroviral therapy in Zambia - a new context for refeeding syndrome? BMJ Case Reports. April 2009.
Ngu JN, Heimburger DC, Arnett DK, Nyirenda C, Potter D, Zulu I, Bosire C, Bagchi S, Ye J, Chi B, and Kabagambe E.K. Fasting Triglyceride Concentrations are associated with Early Mortality Following Antiretroviral Therapy in Zambia. NAJMS 2010;3:79-88.